Alpha Tau Medical Ltd. (id:5485 DRTS)
2.32 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/23/2024 6:50:41 PM)
Exchange closed, opens in 1 day 14 hours
0.43 USD (0.43%)
3.11 USD (3.11%)
4.50 USD (4.50%)
-11.45 USD (-11.45%)
-24.43 USD (-24.43%)
-77.03 USD (-77.03%)
About Alpha Tau Medical Ltd.
Market Capitalization 156.33M
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
| Headquarters (address) |
Kiryat Hamada Street 5 Jerusalem 9777605 Israel |
| Phone | 972 3 577 4115 |
| Website | https://www.alphatau.com |
| Employees | 121 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | DRTS |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.75 - 3.40 |
| Market Capitalization | 156.33M |
| P/E trailing | -5.52 |
| P/E forward | -4.55 |
| Price/Book | 2.11 |
| Beta | 0.771 |
| EPS | -0.410 |
| EPS Israel (ID:92, base:52) | -0.441 |